• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物引起的全身性过敏性皮炎(全身性接触性皮炎):综述。

Systemic allergic dermatitis (systemic contact dermatitis) from pharmaceutical drugs: A review.

机构信息

Dermatologist np, Wapserveen, The Netherlands.

出版信息

Contact Dermatitis. 2022 Mar;86(3):145-164. doi: 10.1111/cod.14016. Epub 2021 Dec 27.

DOI:10.1111/cod.14016
PMID:34837391
Abstract

The literature on systemic allergic dermatitis (SAD; also known as systemic contact dermatitis) is reviewed. Both topical drugs (from absorption through mucosae or skin) and systemic drugs (oral, parenteral, rectal) may be responsible for the disorder. The topical route appears to be rare with 41 culprit topical drugs found to cause SAD in 95 patients. Most reactions are caused by budesonide (especially from inhalation), bufexamac, and dibucaine. SAD from systemic drugs is infrequent with 95 culprit drugs found to cause SAD in 240 patients. The drugs most frequently implicated are mitomycin C, methylprednisolone (salt, ester), and hydrocortisone (salt). The largest group of culprit drugs consisted of corticosteroids (19%), being responsible for >30% of the reactions, of which nearly 40% were not caused by therapeutic drugs, but by drug provocation tests. The most frequent manifestations of SAD from drugs are eczematous eruptions (scattered, widespread, generalized, worsening, reactivation), maculopapular eruptions, symmetrical drug-related intertriginous and flexural exanthema (SDRIFE [baboon syndrome]) and widespread erythema or erythroderma. Therapeutic systemic drugs hardly ever cause reactivation of previously positive patch tests and infrequently of previous allergic contact dermatitis. The pathophysiology of SAD has received very little attention. Explanations for the rarity of SAD are suggested.

摘要

本文回顾了全身性过敏性皮炎(SAD;也称为全身性接触性皮炎)的文献。局部药物(通过黏膜或皮肤吸收)和全身药物(口服、注射、直肠)都可能导致这种疾病。局部途径似乎很少见,有 41 种局部药物在 95 例患者中引起 SAD。大多数反应是由布地奈德(特别是吸入)、布非昔单抗和丁卡因引起的。全身性药物引起的 SAD 很少见,有 95 种全身药物在 240 例患者中引起 SAD。最常涉及的药物是丝裂霉素 C、甲泼尼龙(盐、酯)和氢化可的松(盐)。最常见的致病药物是皮质类固醇(19%),占反应的 30%以上,其中近 40%不是由治疗药物引起的,而是由药物激发试验引起的。药物引起的 SAD 最常见的表现是湿疹样皮疹(分散、广泛、全身性、加重、再激活)、斑丘疹、对称药物相关性间擦疹和皱褶部疹(SDRIFE [狒狒综合征])和广泛的红斑或红皮病。治疗性全身药物很少引起先前阳性斑贴试验的再激活,也很少引起先前的过敏性接触性皮炎。SAD 的病理生理学很少受到关注。本文提出了导致 SAD 罕见的一些原因。

相似文献

1
Systemic allergic dermatitis (systemic contact dermatitis) from pharmaceutical drugs: A review.药物引起的全身性过敏性皮炎(全身性接触性皮炎):综述。
Contact Dermatitis. 2022 Mar;86(3):145-164. doi: 10.1111/cod.14016. Epub 2021 Dec 27.
2
A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.系统性接触性皮炎和对称性药物相关的间擦疹和屈侧疹(SDRIFE)的系统方法:更仔细地观察这些情况和间擦疹的处理方法。
Am J Clin Dermatol. 2011 Jun 1;12(3):171-80. doi: 10.2165/11539080-000000000-00000.
3
Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?全身性药物引起的狒狒综合征:SDRIFE与过敏性接触性皮炎综合征之间存在冲突吗?
Contact Dermatitis. 2004 Nov-Dec;51(5-6):297-310. doi: 10.1111/j.0105-1873.2004.00445.x.
4
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs.药物发疹时的斑贴试验:发疹与致敏药物的实用方面和文献复习。
Dermatitis. 2022;33(1):16-30. doi: 10.1097/DER.0000000000000839.
5
First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?首例与利斯的明相关的对称性药物诱发的间擦疹和屈侧疹(sdrife)?
Am J Clin Dermatol. 2011 Jun 1;12(3):210-3. doi: 10.2165/11318350-000000000-00000.
6
Unveiling the hidden culprit: A case report of recurrent SDRIFE caused by a systemic corticosteroid masquerading as antibiotic allergies.揭开隐藏的罪魁祸首:一例伪装成抗生素过敏的全身性皮质类固醇导致复发性SDRIFE的病例报告。
Contact Dermatitis. 2024 Jul;91(1):88-90. doi: 10.1111/cod.14558. Epub 2024 Apr 4.
7
Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.经皮肤试验证实的多西他赛诱导的对称性药物相关性屈侧和间擦疹(SDRIFE)
Contact Dermatitis. 2024 May;90(5):525-527. doi: 10.1111/cod.14505. Epub 2024 Jan 23.
8
Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.狒狒综合征与化疗所致中毒性红斑:褶皱(间擦部位)性皮肤病。
Clin Dermatol. 2015 Jul-Aug;33(4):462-5. doi: 10.1016/j.clindermatol.2015.04.008. Epub 2015 Apr 7.
9
Multiple corticosteroid orally elicited allergic contact dermatitis in a patient with multiple topical corticosteroid allergic contact dermatitis.一名患有多种外用糖皮质激素过敏性接触性皮炎的患者口服多种糖皮质激素后引发了过敏性接触性皮炎。
Cutis. 2000 May;65(5):307-11.
10
A rare case of musk antihemorrhoids ointment-induced symmetrical drug-related intertriginous and flexural exanthema.麝香痔疮膏诱发的罕见对称性药物相关性擦烂和屈侧疹病例。
Contact Dermatitis. 2020 Nov;83(5):409-411. doi: 10.1111/cod.13574. Epub 2020 Aug 20.

引用本文的文献

1
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.更新非甾体抗炎药超敏反应的分类与常规诊断:世界变态反应组织声明
World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086. eCollection 2025 Aug.
2
Serendipitous and Systematic Chemoproteomic Discovery of MBLAC2, HINT1, and NME1-4 Inhibitors from Histone Deacetylase-Targeting Pharmacophores.从靶向组蛋白去乙酰化酶的药效团中偶然发现并系统化学蛋白质组学鉴定出MBLAC2、HINT1和NME1-4抑制剂
ACS Chem Biol. 2025 Jun 20;20(6):1247-1257. doi: 10.1021/acschembio.5c00108. Epub 2025 May 8.
3
Increased Rates of Gold and Acrylate Allergy in Individuals with Fibromyalgia Tested with an Extended Dental Patch Test Series.
纤维肌痛患者经扩展牙贴试验系列检测出金和丙烯酸盐过敏率增加。
Acta Derm Venereol. 2023 Dec 11;103:adv22336. doi: 10.2340/actadv.v103.22336.
4
Systemic allergic contact dermatitis to palladium, platinum, and titanium: mechanisms, clinical manifestations, prevalence, and therapeutic approaches.对钯、铂和钛的全身性过敏性接触性皮炎:发病机制、临床表现、患病率及治疗方法
MedComm (2020). 2023 Oct 21;4(6):e386. doi: 10.1002/mco2.386. eCollection 2023 Dec.
5
ameliorates irritant contact dermatitis by suppressing NF‑κB p65‑dependent inflammatory responses in mice.通过抑制小鼠中NF-κB p65依赖性炎症反应来改善刺激性接触性皮炎。
Exp Ther Med. 2023 Aug 2;26(3):446. doi: 10.3892/etm.2023.12145. eCollection 2023 Sep.
6
Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease. 与治疗消化性溃疡和胃食管反流病的其他药物相比,瑞巴派特常见的不良反应。
Sci Rep. 2022 May 12;12(1):7839. doi: 10.1038/s41598-022-11505-0.